157. スタージ・ウェーバー症候群
[臨床試験数:8,薬物数:11(DrugBank:4),標的遺伝子数:5,標的パスウェイ数:62

Searched query = "Sturge-Weber syndrome", "Síndrome de Sturge-Weber"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03047980
(ClinicalTrials.gov)
January 20172/2/2017Trial of Sirolimus for Cognitive Impairment in Sturge-Weber SyndromeTrial of Sirolimus for Cognitive Impairment in Sturge-Weber SyndromeSturge-Weber SyndromeDrug: SirolimusAnne Comi, MDChildren's Hospital Medical Center, Cincinnati;Pfizer;National Institutes of Health (NIH);Faneca 66 Foundation;National Institute of Neurological Disorders and Stroke (NINDS)Active, not recruiting3 Years31 YearsAll10Phase 2/Phase 3United States
2NCT02080624
(ClinicalTrials.gov)
January 201118/4/2013Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber SyndromePhase II, Randomized, Triple Blind, Intra-individually Placebo-controlled Clinical Trial to Assess the Efficacy and Safety of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome.Sturge- Weber SyndromeDrug: Drug: Topical RapamycinClinica Universidad de Navarra, Universidad de NavarraNULLCompleted16 Years65 YearsBoth23Phase 2Spain